There were numeric absolute risk reductions in all-cause mortality (ICD vs amiodarone: 23.3% vs 27.0%) and arrhythmic mortality (ICD vs amiodarone: 9.8% vs 11.9%) at 3 years, although these did not reach statistical significance.
1
—
—
There were numeric absolute risk reductions in all-cause mortality (ICD vs amiodarone: 23.3% vs 27.0%) and arrhythmic mortality (ICD vs amiodarone: 9.8% vs 11.9%) at 3 years, although these did not reach statistical significance.